Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2005

Conditions
Atopic Dermatitis
Interventions
DRUG

NF-kappaB Decoy

Trial Locations (9)

10029

Mount Sinai School of Medicine, New York

14609

Helendale Dermatology & Medical Spa, LLP, Rochester

33136

University of Miami Skin Research, Miami

53719

Madison Skin & Research, Inc., Madison

55432

Minnesota Clinical Study Center, Fridley

77030

Center for Clinical Studies, Houston

77058

Center for Clinical Studies, South Houston

78759

Derm Research, Inc., Austin

97201

Oregon Health & Science University, Department of Dermatology, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Anesiva, Inc.

INDUSTRY

NCT00125333 - Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis | Biotech Hunter | Biotech Hunter